NCT03081403 (SENSISKIN) is a NA clinical trial of Quantitative Sensory Testing in Sensitive Skin, sponsored by University Hospital, Brest.

Who is sponsoring NCT03081403?

NCT03081403 is sponsored by University Hospital, Brest.

What drugs are being tested in NCT03081403?

Interventions in NCT03081403: Quantitative Sensory Testing.

What condition does NCT03081403 study?

NCT03081403 studies Sensitive Skin.

Is NCT03081403 still recruiting?

NCT03081403 is currently completed. Last updated 4 February 2025.

Last reviewed 2025-02-04 · How we verify

NCT03081403: SENSISKIN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quantitative Sensory Testing in Subjects With Sensitive Skin or Not

Completed NA Last updated 4 February 2025

What this trial tests

NA trial testing Quantitative Sensory Testing in Sensitive Skin in 42 participants. Completed in 27 October 2017.

Timeline

14 April 2017

Primary endpoint
22 September 2017

27 October 2017

Quick facts

Lead sponsor	University Hospital, Brest
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	42
Start date	14 April 2017
Primary completion	22 September 2017
Estimated completion	27 October 2017
Sites	1 location across France

Drugs / interventions tested

Quantitative Sensory Testing

Conditions studied

Sensitive Skin — all drugs for Sensitive Skin →

Sponsor

University Hospital, Brest

Who can join

Adults 20 to 60, any sex, with Sensitive Skin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sensitive skin is a common problem, with 50% of women and 30% of men in Europe feel they have sensitive skin. The Quantitative sensory testing (QST) is a physico-psychic method that uses gradients stimuli of different modalities to measure a subjective somatosensory response. This allows to characterize sensory dysfunction by assessing the participation of small and large nerve fibers. The aim of this project is to characterize the presence or absence of a neurological disorder in patients with sensitive skin. This discovery would be a decisive argument to reinforce the suspicion that sensitive skins is linked to a small fiber neuropathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Quantitative Sensory Testing

Trials testing the same drug.

NCT06439004 — The Use of QST to Characterize Somatosensory Functionality · NA · completed
NCT06429371 — Biopsychosocial Contributors to Irritability in Individuals With Shoulder Pain · recruiting
NCT05147454 — MRI & QST Analysis in Trigeminal Neuralgia and Persistent Idiopathic Facial Pain · active not recruiting
NCT04685343 — Behavioral and Neural Phenotypes of Primary Dysmenorrhea in Adolescents · NA · completed
NCT04443452 — Molecular Pathways Involved in Knee Pain · completed

Other recruiting trials for Sensitive Skin

Currently open trials in the same condition.

NCT06516939 — The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin · NA · recruiting

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03081403 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 4 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03081403.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing